Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is a positive update. Stock moved all the way up to 6 cents. Will be interesting to see how it trades for the next week.
I think my hypothetical update was much better (5 people, lol. Nailed it.)
Point taken sir ~
Thank you for your clear mindedness .
I have lost a number of close friends to cancer recently so I guess I'm
excited about the prospect of a early diagnosis for future cancer patients and possible cure.
Monetary gain here would be nice if it comes .
Klarino man, I would couch that statement with the fact that it is still preliminary and limited results based on 5 patient, so still halfway up on this medical ladder.
It is good news though, having the "imaging agent" reach the lymph nodes is half the battle for this tech and certainly for this study.
Like I posted previously, even with bad news or the perception by others as bad news, it is an update and shareholders & investor will approve and show their approval.
There you go ~
Tremendous possibilities ahead.
Thank you Gorcon, and thank you Bob for the update.
As I have been hoping for and whining about, an update.
Not the blow me off my shoes update but a positive update nonetheless.
I wonder if Proulx was reading my posts. LOL
Good move IBX.
mhtx at .026? Not bloody likely, unless the marv has a $15 million life insurance policy with mhtx shareholders as beneficiaries. Again, not bloody likely. And why only looking for a double? What happened to those 100% buy ratings claiming mhtx going to 11 cents and ibx going to 40 cents?
Much more realistic to guess which one trades below a penny first. The odds say mhtx, but Proulx seems to be doing (or not doing) everything he can to help ibx win the race.
Yes my friend ,a good time to purchase some (buy low )cheap shares as you say .
A double for sure !
We Wish for more available shares @ these $$$.
All the ibx shareholders dumping shares under 5 cents just don't seem to share your imagination.
This company's symbol, HDT, is shown as a recipient of IBX's nanoparticles put out earlier on a flyer. The other two on that flyer are NewPhase and SECA Animal Research. Imagine the potential of this trial...$$$ Oh forgot that they are going bankrupt...LOL
https://www.clinicaltrialsarena.com/news/hdt-bio-vaccine-trial/
LMAO,
You should apply for a PR job at IBX. They have lots of cash on hand.
What will he say? Something like this:
Hello shareholders, this is Proulx coming to you from beautiful Lake Tahoe where the snow has been piling up almost as fast as the number of ibx shares outstanding. While I am enjoying life here, I can report to you that after a year and a couple of months we have already enrolled 5 people in our pivotal study. Diving in deeper, that means we're 1/3 of the way there and it only took a little over a year. Meanwhile I'm spending cash like crazy and based on the share price action will have to raise more funds at ridiculously low prices. Thanks to all you loyal shareholders and a big "my bad" to those who bought in at 20 cents. Yours truly, Bob Proulx (having a great time with my finger in the wind and, after more than 6 years in charge, still waiting for a clue about whether this magsense stuff actually makes sense).
Just as I posted weeks ago, Proulx needs to tell shareholders and give us a deeper dive into the studies.
IMHO The longer he avoids it, the deeper the dive will go.
A simple, no BS, double talk press release will change this dive.
Meanwhile, a good time for me to pick up some cheap shares.
I still believe that the tech is rock solid and when any positive news is announced it will really be a quick double from here.
Do you own DD and good luck.
ibx down to $.044 with over 7 million shares traded. Don't tell me there isn't something rotten down under.
Can't give results when unable to enroll the 15 people required for the trial. Obviously no incentive for participating in this poorly designed fiasco. Proulx better not be getting any new stock options or salary increase this year. Lake Tahoe for the winter season - shameless, just like manny and marv.
Cash will be an issue but not for some time to come.
Lack of news on the study is hurting the company. The longer Proulx takes to give real results, even if its on a small sample of patients the worst it will be for IBX.
That cash balance is going down every day and trial still not fully enrolled. ibx now .046 which means Proulx will be raising cash again soon to keep his paychecks coming in to Lake Tahoe (or maybe move to a summertime hot spot?). Such pitiful performance for investors who invested at 20 cents.
Just pointing out how claims of taking on shares are contradicted by the lack of volume. Also how .0135 is too high to attract buyers.
Embarrassed or not, I and many shareholders want to know the background and stats to the study.
Yes, I know, that Covid set everything back but it's okay, I and many shareholders can digest the good or the bad.
I am not interested in what mhtx says or does as it is inexorably tied to IBX.
Simple stuff really. IBX stock goes up, MHTX stock goes up.
There is no real purpose in complaining about lack of volume or share price, so why keep doing it.
No volume again. Is 1 1/3 pennies really too high for mhtx? Tells a lot, as actions speak louder than words.
I agree with you .
88,000 shares (tip of iceberg) for sale and no one will "take them".
Does that question really need to be asked? It is obvious that after more than a year Proulx still can't get 15 people to enroll in this poorly designed study. The shady statement that "multiple" people have enrolled tells it all. When you only need 15 people, how hard would it be to give an exact count? Proulx just too embarrassed to report it.
Proulx has been in charge for over 6 yeears and still sitting around with a finger in the wind, still waiting to find out if the technology actually works. He should be replaced and the share price, now below 5 cents, reflects it.
While we're at it, why no update from manny and marv for over a year? Sucking shareholders dry for over a decade - lock them up.
The real point is why is Proulx delaying telling us about the study?
We need more on this very important subject.
No use in hiring more people, growing out the lab in San Diego if the study is not successful.
The rest is just noise for me.
Not bashing here, just want to know more about the study which is the base holding up the stock.
The tech may be solid but the man behind the controls needs to step up.
The point is that no one will pay .0135 for mhtx shares. Volume 605 shares today. If such great value here, why is .0135 too high?
You won't be sorry ,be patient ~ from a trading perspective ,you can double just stay woke.
Everything else here is bash news that no one cares about.
I picked up some shares yesterday.
The Dow & Nasdaq dropped again today, investors are spooked by Putin and his war.
Inflation hitting hard. Not fun times for anyone.
Another day and no one interested in taking shares for 1 1/3 pennies/share. 605 shares total volume even with the asking price at just $.0135 - looks like that is just too high a price for manny and marv's gravy train express.
Not even a shareholder update; last one was February 2021. Come on you guys, move away from the lobster buffet and do some work for your shareholders.
Unlimited supply of mhtx available at .0135, but no one will take them.
ibx $.05
Will Proulx ever stop the winter party at Lake Tahoe and actually do the work required to get the 15 people needed for this trial that is now well over 1 year old? He's been running the show for this imaging technology for over 6 years and still just sitting around with his finger in the wind? Time for some changes before ibx shares fall as far as mhtx.
ibx $.05
Will Proulx ever stop the winter party at Lake Tahoe and actually get the 15 people needed for this trial that is now well over 1 year old? He's been running the show for this imaging technology for over 6 years and still just sitting around with his finger in the wind? Time for some changes before ibx shares fall as far as mhtx.
Yes I agree. The SP fully reflects this and it’s worth only half the ipo price. Glad it took the advice and shorted the Bejeebers out of this company also!!!
Good to agree on something - no more hype is needed, it doesn't work and hasn't for years.
Actually, I give Proulx credit for including the truth in his promo interviews. Listen carefully and you can find the real story. That is my main source when I post about no human instrument (in spite of hype from some outside the company that it had been designed, developed and included in this first trial), when I post about the stock price (in spite of hype about 40 cents/share, again from outsider), when I cite that cash is enough to get to the end of this first trial, when I point to all the dilution.
It is disappointing to see Proulx continue to report that multiple people have been enrolled in the trial. Only 15 are needed and the last real number given was 3. Why be so coy and say multiple instead of an actual number? The whole year long+ trial and still not fully enrolled is an embarrassment.
Let's call it like it is - over a decade and still only as far as this phase 1 safety trial and a finger in the wind to decide what to do in the future. Investors and the share price certainly aren't celebrating any great accomplishments, at least not yet.
Well, we can agree on one thing,
I am also the tired of "hyped up promotions or unfulfilled p/r promises" this is why I like this point in time and the very clear message Bob just put out.
Please mhtx and ibx, no more hyped up press releases, or paid promotions or videos!!!!
How about a video of the new lab? or an update on the new nanoparticles?
Stand on your merits going forward. Show us real progress and the world will believe you.
I am also tired of the same old, same old negative posts.
Ok, that's it for my Friday grumbling.
Tired of the price-doesn't-matter mantra. It does and both ibx and mhtx price charts are horrendous. What's over the top is the endless stream of links to promotional interviews and claims of how well everything is going when things haven't gone well for many, many years.
When I am wrong I will freely admit it. Don't know why that is so difficult for some to do. I agree with you on one thing, stocks do follow the news (not the hyped up promotions or unfulfilled p/r promises). Unfortunately, the real news is that after more than a decade there is still no human instrument; after a year the trial is still not fully enrolled; and the stock price fully reflects this as it is worth less than half of the original ipo price.
Yes, we know, we know, we are not totally brain dead.
It's a long game and either you are in the stock or out.
You want to stay out, that is your prerogative but the endless repetition is a little over the top.
Overall, I would say it was a good year and I believe it will only get better. The stock will follow the news.
Good year unless you owned ibx shares and believed the hype about them going to 40 cents. Or if you owned mhtx shares and believed the hype about them going to 11 cents.
Funny how any mention of stock performance was absent from the 2021 recap.
Cash balance for December 31 in the previous year was 13.2 million.
It was a very good year and here are the 2021 Highlights
Multiple Patients enrolled & completed the Magsense HER2 Breast Cancer Phase 1 Study.
Four Clinical Sites in VIC, NSW and QLD are participating in the Phase 1 Study.
Secured New Premises expanding R&D and manufacturing capabilities
Collaboration with Patrys Limited looks toward a potential new imaging agent for breast cancer
Joint Development Agreement with Global Cancer Technology aims to develop nanoparticle technology for treating breast cancer.
Revenues from sales of IBX's super-paramagnetic iron oxide nanoparticles to external parties remains steady.
Imagion recieved $2.6 million in R&D incentives
Cash balance of $13.4 million as of 31 Decenmber 2021
.058, .012, pat yourself on the back.
MAGNETIC MOLECULAR
IMAGING
ONE STEP CLOSER TO THE EARLY
DETECTION OF CANCER
2021 was a very important year for Imagion as we became a
clinical stage company with the commencement of our first-inhuman study of the MagSense® technology for HER2 breast
cancer.
Imagion’s MagSense® technology has the potential to provide
more specific and sensitive detection for cancer than current
imaging technologies. By using tiny magnetic nanoparticles to
identify tumors, our MagSense® technology does not require
use of radioactivity, making it a safer alternative for noninvasive detection.
With a safer, more specific, and more sensitive approach
the Company hopes to enable a new standard of care in the
detection of cancer and other diseases. One that will minimize
the need for biopsies and thereby reducing costs while
minimizing risks for patients.
The current Phase I study of the MagSense® HER2 breast
cancer imaging agent is our first clinical investigation. it is an
important and valuable step forward serving as a proof-ofprinciple that our magnetic molecular imaging technology has
potential to change clinical practices. But it’s just the start.
There are many types of cancer and other diseases that can
benefit from earlier, better, and safer detection.
We’re now one step closer to making a breakthrough in medical
imaging.
Imagion starts 2022 in a strong financial position with our
clinical study well underway and momentum in our research
programs. We are looking forward to bringing our Phase I study
to conclusion and executing our next phase of development.
We are grateful to all our stakeholders - collaborators, patients
that participate in the study, employees, and shareholders - for
their ongoing commitment and support and we look forward to
updating you with progress throughout the year.
On page 22of the Results presentation
"Current Phase 1 study
provides proof-of-concept
that MagSense® imaging is
effective and provides path
to commercialization."
If you're an investor in MHTX, then you're an investor in IBX / IBXXF . Take a victory lap and pat yourself on the back. We've now reached a omni important tipping point. 1/4 four of the annual report for MHTX is due in April, and we can expect to see "Royalty Revenue INCOME" from our Medical Metal Alloy Manufacturer. Hopefully the 1st of a steady stream of quarterly income reports that INCREASE as they progress
Nothing to worry about, I'm loaded and ready for anything.
Packing bags now.
Meanwhile, even though I am not a big fan of this publication, they are
"Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate", I'm not either.
https://simplywall.st/stocks/au/healthcare/asx-ibx/imagion-biosystems-shares/news/were-not-very-worried-about-imagion-biosystems-asxibx-cash-b-1
Watch out for the wild bear. I hear it haS broken into 28 homes up there...LOL
What once was good, can easily go bad and what once was bad can easily go good. hoot hoot.
But, not the prediction of going bankrupt. LMAO
Your sad, I am very happy, heading to the party at Lake Tahoe.
I will report on happenings later, stay tuned.
Party a Lake Tahoe, I'm there!! LMAO
ibx $.056, perky, perky, perky. Must be selling tons of nanoparticles. Can mhtx hold above a penny with ibx falling like a rock? So sad.
Party at Lake Tahoe!!!
Best you can come up with is a made up fake quote? A nowhere looking statement? so sad
What once was good, can easily go bad and what once was bad can easily go good. hoot hoot.
But, not the prediction of going bankrupt. LMAO
Followers
|
83
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9558
|
Created
|
11/30/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |